Stress and reproductive disorders: modern views on the problem and own research experience

Authors

  • Seliukova N. Yu. SI «V. Danilevsky Institute of Endocrine Pathology Problems of NAMS of Ukraine», Kharkiv, Ukraine; National University of Pharmacy, Kharkiv, Ukraine
  • Gladkova A. I. SI «V. Danilevsky Institute of Endocrine Pathology Problems of NAMS of Ukraine», Kharkiv, Ukraine
  • Koreneva E. M. SI «V. Danilevsky Institute of Endocrine Pathology Problems of NAMS of Ukraine», Kharkiv, Ukraine
  • Yaremenko F. G. SI «V. Danilevsky Institute of Endocrine Pathology Problems of NAMS of Ukraine», Kharkiv, Ukraine
  • Kustova S. P. SI «V. Danilevsky Institute of Endocrine Pathology Problems of NAMS of Ukraine», Kharkiv, Ukraine
  • Misyura E. V. SI «V. Danilevsky Institute of Endocrine Pathology Problems of NAMS of Ukraine», Kharkiv, Ukraine
  • Kravchun N. O. SI «V. Danilevsky Institute of Endocrine Pathology Problems of NAMS of Ukraine», Kharkiv, Ukraine
  • Karachentsev Yu. I. SI «V. Danilevsky Institute of Endocrine Pathology Problems of NAMS of Ukraine», Kharkiv, Ukraine

DOI:

https://doi.org/10.21856/j-PEP.2019.1.11

Keywords:

male infertility, pathospermia, spermatogenesis

Abstract

Modern therapy of infertility in men is mainly associated with the use of hormonal and anti-hormonal drugs, but hormonal therapy often leads to a number of negative complications. The list of non-hormonal nature is extremely limited, which is why the study of effective and safe non-hormonal drugs for the treatment of pathospermia and infertility remains an urgent task. The purpose of our work was to evaluate the effectiveness of the new biologically active compound Katiazin — a non-hormonal medicine — for the treatment of pathospermia. The work was performed on sexually mature 6-month rats’ males of the Vistar population. To simulate the pathology of spermatogenesis, animals were stressed for seven days by daily one-hour immobilization on the back with fixation of both pairs of paws. The appointment of Katiazin was carried out from the first day of male exertion in a dose of 0.6 mg/kg body weight daily for 21 days intragastrically. Generative function of males was estimated by the indicators of spermogram and morphometric analysis of the histological structure of the testicles. It was founf that stressing of rats affects all the indicators of spermatogenesis, namely, the amount and mobility of spermatozoa decreases and, conversely, the percentage of pathological cells increases. In animals who taking the Katiazin, all the parameters of spermogram of rats were improved. The analysis of morphometric data suggests that the formation of germ cells at the stage of maturation of sperm from the spermatoid and the stage of spermatogenesis is activated under the influence of Katiazin. The results allow us to recommend Katiazin for the development of a new drug for the treatment of male infertility.

References

Serdjuk AM, Kundijev JuI, Nagorna AM, Shyrobokov VP. Zhurn NAMN Ukrai'ny 2012; 18 (3): 358-371.

Morin SJ, Scott RT Transl Androl Urol 2018; 7 (3): S283-S291. doi: http://doi.org/10.21037/tau.2018.05.02.

Santi D, De Vincentis S, Magnani E, Spaggiari G. Andrology 2017; 5 (4): 695-703. doi: http://doi.org/10.1111/andr.12379.

Sengupta P, Borges EJr, Dutta S, Krajewska-Kulak E.Hum Exp Toxicol 2018; 37 (3): 247-255. doi: http://doi.org/10.1177/0960327117703690.

Levine H, Jørgensen N, Martino-Andrade A, et al. Hum Reprod Update 2017; 23: 646-659. doi: http://doi.org/10.1093/humupd/dmx022.

Volkova NO, Juhta MS, Chernishenko LG, et al. Problemy Kriobiologii i Kriomediciny 2017; 27 (3): 203-218.

Nikiforov OA, Avramenko NV, Lomejko EA, Bachurin GV. Aktual'nye voprosy farmacevticheskoj i medicinskoj nauki i praktiki 2015; 3 (19): 76-80.

Knez J. Reprod Biomed Online 2013; 26: 440-448. doi:http://doi.org/10.1016/j.rbmo.2013.02.005.

Bonde JP. Curr Opin Endocrinol Diabetes Obes 2013;20: 234-239. doi: http://doi.org/10.1097/MED.0b013e32835f3d4b.

Sharma R, Biedenharn KR, Fedor JM, Agarwal A. Reprod Biol Endocrinol 2013;11: 66. doi: http://doi.org/10.1186/1477-7827-11-66.

Ren L, Li X, Weng Q, et al. J Vet Med Sci 2010; 72: 1501-1506.

Bykova MV. Narushenie redoks-balansa spermatozoidov i semennoj plazmy muzhchin pri patospermii, Krasnojarsk,2008: 24 p.

Chystjakova EJe, Gladkova AI. Probl Endokryn Patologii'2008; 4: 84-91.

Gorpynchenko II, Romanjuk MG. Zdorov'e Muzhchiny 2016; 1 (56): 8-17.

Patent 38130A. 3-(4,5-Dygidrotiazol-2-il)amid cys-1,2,2-trymetylcyk-lopentan-1,3-dykarbonovoi' kysloty, shho stymuljuje spermatogenez.

Zolotuhyna VM, Nykytchenko JuV, Jaremenko FG,Zolotuhyna AA. Nauka i social'ni problemy suspil'stva: medycyna,farmacija, biotehnologija: Tez. Dop, Harkiv, 2003; 2: 82.

Gladkova AI, Sidorova IV, Jaremenko FG, Zolotuhina VN. Probl Endokryn Patologii' 2012; 4: 102-108.

Valuskova P, Farar V, Janisova K, et al. Stress 2017;20 (1): 36-43. doi: http://doi.org/10.1080/10253890.2016.1263836.

Török B, Sipos E, Pivac N, Zelena D. Prog Neuropsychopharmacol Biol Psychiatry 2019; 90: 117-133. doi: http://doi.org/10.1016/j.pnpbp.2018.11.013.

Chistjakova E. Є. Probl Endokryn Patologii' 2008; 2: 43-49.

Ren L, Li X, Weng Q, et al. J Vet Med Sci 2010; 72: 1501-1506.

Tjuzikov IA, Kalinchenko SJu, Vorslov LO, Tishova JuA. Jeksperimental' naja i klinicheskaja urologija 2014; 2: 68-75.

Bondarenko VA, Karpenko NA, Velichko NF, et al. Zdorov'e Muzhchiny 2014; 1 (48): 142-144.

Downloads

Published

2021-07-06

How to Cite

Seliukova, N. Y. ., Gladkova, A. I. ., Koreneva, E. M., Yaremenko, F. G. ., Kustova, S. P. ., Misyura, E. V. ., Kravchun, N. O. ., & Karachentsev, Y. I. . (2021). Stress and reproductive disorders: modern views on the problem and own research experience. Problems of Endocrine Pathology, 67(1), 87-94. https://doi.org/10.21856/j-PEP.2019.1.11

Most read articles by the same author(s)

1 2 3 4 > >>